AMPE News and Press, Ampio Pharmaceuticals Inc. From 04/06/21

Ampio Pharmaceuticals' Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus Nephritis Laboratory results suggest Ampion's suitability for addressing kidney diseases and provides further evidence it is a platform biologic for treatment of inflammatory and ...

Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress The company's findings will be showcased to over 400 clinicians, respiratory health and critical care professionals, aerosol scientists, engineers, product d...

Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap Conference PR Newswire ENGLEWOOD, Colo. , March 19, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immu...

Shares of Ampio Pharmaceuticals (AMPE) are up 7.5% to $1.95 in morning trading after the company reported preliminary positive phase 1 results for AP-014, an inhaled treatment for respiratory distress in patients with COVID-19.AP-014 is testing an inhaled version of the company's Am...

Ampio Pharmaceuticals ([[AMPE]] +4.7%) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in patients as a result of COVID-19.The company also outlined its progress toward initiating a Phase I clinical tria...

Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress Also provides updates on (i) forthcoming Phase I clinical trial utilizing inhaled Ampion to treat "long hauler" COVID-19 symptoms and (ii) research into indications in kidney...

This continues our series on busting options myths where we explore a different way to sell options. In this article, we discuss myths around selling puts. These myths generally teach: (i) only sell puts on companies you wouldn't mind owning; (ii) selling puts requires a neutral t...

Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 PR Newswire ENGLEWOOD, Colo. , March 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the ad...

Shares of Ampio Pharmaceuticals (NYSEMKT: AMPE) were jumping 8.4% as of 11:51 a.m. EST on Thursday. The nice gain came after the company provided its fourth-quarter update following the market close on Wednesday. Investors probably didn't care all that much about Ampio's Q4 resu...

Gainers: Five Prime Therapeutics (FPRX) +78%, Ampio Pharmaceuticals (AMPE) +10%, Soligenix (SNGX) +7%.Losers: BioVie (BIVI) -29%, Schrodinger (SDGR) -25%, KemPharm (KMPH) -19%, Anchiano Therapeutics (ANCN) -15%, AbCellera Biologics (...